Mouse HSA+ immature cardiomyocytes persist in the adult heart and expand after ischemic injury

PLoS Biol. 2019 Jun 27;17(6):e3000335. doi: 10.1371/journal.pbio.3000335. eCollection 2019 Jun.

Abstract

The assessment of the regenerative capacity of the heart has been compromised by the lack of surface signatures to characterize cardiomyocytes (CMs). Here, combined multiparametric surface marker analysis with single-cell transcriptional profiling and in vivo transplantation identify the main mouse fetal cardiac populations and their progenitors (PRGs). We found that CMs at different stages of differentiation coexist during development. We identified a population of immature heat stable antigen (HSA)/ cluster of differentiation 24 (CD24)+ CMs that persists throughout life and that, unlike other CM subsets, actively proliferates up to 1 week of age and engrafts cardiac tissue upon transplantation. In the adult heart, a discrete population of HSA/CD24+ CMs appears as mononucleated cells that increase in frequency after infarction. Our work identified cell surface signatures that allow the prospective isolation of CMs at all developmental stages and the detection of a subset of immature CMs throughout life that, although at reduced frequencies, are poised for activation in response to ischemic stimuli. This work opens new perspectives in the understanding and treatment of heart pathologies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD24 Antigen / metabolism*
  • CD24 Antigen / physiology
  • Cell Differentiation
  • Cell Lineage / physiology*
  • Female
  • Heart / growth & development
  • Heart / physiology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocardial Ischemia / metabolism
  • Myocardial Ischemia / physiopathology
  • Myocardium / metabolism
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / physiology
  • Regeneration / physiology
  • Single-Cell Analysis

Substances

  • CD24 Antigen
  • Cd24a protein, mouse

Grants and funding

This work was financed by European Structural and Investment Funds (ESIF), under Lisbon Portugal Regional Operational Program and National Funds through FCT-Foundation for Science and Technology under project POCI-01-0145-FEDER-016385 to PPO; by Pasteur Institute, INSERM, ANR (grant Twothyme), REVIVE Future Investment Program and Pasteur-Weizmann Foundation through grants to AC. MV (SFRH/BD/74218/2010) and TPR (SFRH/BPD/80588/2011) were supported by FCT, and PPO was recipient of an invited scientist grant by Institut Pasteur, Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.